Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Cancer: A Population-Based Cohort Study Using a Common Data Model

Studies have reported conflicting results on the association between the use of renin-angiotensin-aldosterone system (RAAS) inhibitors and cancer development. We compared the incidence of cancer between patients using RAAS inhibitors and other antihypertensive drugs. This retrospective observational...

Full description

Bibliographic Details

Published in:	Diagnostics
Main Authors:	Seung-Hwa Lee, Jungchan Park, Rae Woong Park, Seo Jeong Shin, Jinseob Kim, Ji Dong Sung, Dae Jung Kim, Kwangmo Yang
Format:	Article
Language:	English
Published:	MDPI AG 2022-01-01
Subjects:	renin-angiotensin-aldosterone system inhibitors cancer occurrence
Online Access:	https://www.mdpi.com/2075-4418/12/2/263